Rita J Desai

Array ( [id] => 5602995 [patent_doc_number] => 20060293340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => '2-Aminopyrimidine derivatives as raf kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/560352 [patent_app_country] => US [patent_app_date] => 2004-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15792 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293340.pdf [firstpage_image] =>[orig_patent_app_number] => 10560352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614462 [patent_doc_number] => 20060116390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Hepatitis c virus inhibitors' [patent_app_type] => utility [patent_app_number] => 10/559746 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46432 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116390.pdf [firstpage_image] =>[orig_patent_app_number] => 10559746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256645 [patent_doc_number] => 20040259882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor' [patent_app_type] => new [patent_app_number] => 10/860823 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10248 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259882.pdf [firstpage_image] =>[orig_patent_app_number] => 10860823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620079 [patent_doc_number] => 20060189613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)' [patent_app_type] => utility [patent_app_number] => 10/559202 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6765 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189613.pdf [firstpage_image] =>[orig_patent_app_number] => 10559202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265027 [patent_doc_number] => 20040242563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 10/858975 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17720 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242563.pdf [firstpage_image] =>[orig_patent_app_number] => 10858975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061789 [patent_doc_number] => 20050004151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/854484 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16628 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004151.pdf [firstpage_image] =>[orig_patent_app_number] => 10854484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256454 [patent_doc_number] => 20040259864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Substituted pyrimidinone derivatives as ligands of integrin receptors' [patent_app_type] => new [patent_app_number] => 10/469176 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29194 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259864.pdf [firstpage_image] =>[orig_patent_app_number] => 10469176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359768 [patent_doc_number] => 07485647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => '2-aminoquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/556932 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17026 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485647.pdf [firstpage_image] =>[orig_patent_app_number] => 10556932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484628 [patent_doc_number] => 07902192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Inhibitors of P38 and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/556161 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22237 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902192.pdf [firstpage_image] =>[orig_patent_app_number] => 10556161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252710 [patent_doc_number] => 07579344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Pyrimidine derivatives possessing cell-cycle inhibitors activity' [patent_app_type] => utility [patent_app_number] => 10/556607 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14410 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579344.pdf [firstpage_image] =>[orig_patent_app_number] => 10556607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7195098 [patent_doc_number] => 20050051052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Self-assembling dyes' [patent_app_type] => utility [patent_app_number] => 10/844099 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15631 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20050051052.pdf [firstpage_image] =>[orig_patent_app_number] => 10844099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098532 [patent_doc_number] => 20050130991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof' [patent_app_type] => utility [patent_app_number] => 10/839176 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9611 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130991.pdf [firstpage_image] =>[orig_patent_app_number] => 10839176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434890 [patent_doc_number] => 20040266747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Long chain fatty alcohol substituents in antineoplastic agents' [patent_app_type] => new [patent_app_number] => 10/494441 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7139 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266747.pdf [firstpage_image] =>[orig_patent_app_number] => 10494441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051942 [patent_doc_number] => 20070032487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Inhibitors of phosphatidylinositol 3-kinase' [patent_app_type] => utility [patent_app_number] => 10/554559 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25911 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032487.pdf [firstpage_image] =>[orig_patent_app_number] => 10554559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872454 [patent_doc_number] => RE040245 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2008-04-15 [patent_title] => 'Gyrase inhibitors and uses thereof' [patent_app_type] => reissue [patent_app_number] => 10/833995 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16346 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040245.pdf [firstpage_image] =>[orig_patent_app_number] => 10833995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181051 [patent_doc_number] => 20040202624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Galenical formulation' [patent_app_type] => new [patent_app_number] => 10/833137 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9800 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202624.pdf [firstpage_image] =>[orig_patent_app_number] => 10833137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190543 [patent_doc_number] => 20040204410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'CIS-imidazolines' [patent_app_type] => new [patent_app_number] => 10/835021 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21604 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204410.pdf [firstpage_image] =>[orig_patent_app_number] => 10835021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122945 [patent_doc_number] => 20050014774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Oxo-pyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 10/833601 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21540 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014774.pdf [firstpage_image] =>[orig_patent_app_number] => 10833601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378502 [patent_doc_number] => 20040220194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => '2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/829416 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25905 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220194.pdf [firstpage_image] =>[orig_patent_app_number] => 10829416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373392 [patent_doc_number] => 07473695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => '4-imidazolin-2-one compounds' [patent_app_type] => utility [patent_app_number] => 10/827294 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27337 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473695.pdf [firstpage_image] =>[orig_patent_app_number] => 10827294 [rel_patent_id] =>[rel_patent_doc_number] =>)